Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

  • There is currently no data for AGL

Angle News

IN BRIEF: Angle hails publication of research data in science journal
23 Aug 2024

IN BRIEF: Angle hails publication of research data in science journal

Angle PLC - Guildford, England-based liquid biopsy company - Celebrates research data on its Parsortix PC1 system that it says supports approval by th...

IN BRIEF: Angle says open offer raises proceeds of GBP500,000
21 Jun 2024

IN BRIEF: Angle says open offer raises proceeds of GBP500,000

Angle PLC - Guildford, England-based liquid biopsy company - Receives valid applications for a total of 3.6 million open offer shares from qualifying ...

EARNINGS AND TRADING: STV sees advertising upturn; Angle loss narrows
5 Jun 2024

EARNINGS AND TRADING: STV sees advertising upturn; Angle loss narrows

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...

Angle unveils plans to raise more than £10m
5 Jun 2024

Angle unveils plans to raise more than £10m

(Sharecast News) - Liquid biopsy specialist Angle is to raise more than £10m to support future growth, the UK company announced on Wednesday.

TRADING UPDATES: Bens Creek considers administration; Nexxen inks deal
16 May 2024

TRADING UPDATES: Bens Creek considers administration; Nexxen inks deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Angle reports promising results from Parsortix study
16 May 2024

Angle reports promising results from Parsortix study

(Sharecast News) - Angle, the AIM-listed liquid biopsy company which specialises in circulating tumour cell (CTC) solutions, has announced the results...

CORRECT: Angle shares up on assay development deal with AstraZeneca
3 May 2024

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)